Pituitary tumors are relatively common tumors accounting for almost 15% of all primary brain tumors. Pituitary macroadenomas cause mass effect on the optic apparatus causing a myriad of visual deficits. On imaging generally the anterior visual pathway is involved which may be compressed by the mass lesion. Edema in the posterior visual pathway, i.e., optic tracts on magnetic resonance imaging is a relatively common finding in craniopharyngiomas and other metastatic lesions in the pituitary region. Edema in the optic tracts in pituitary macradenomas is a very rare entity as reported by various authors in literature. We report a case of optic tract edema in a case of pituitary macroadenoma which caused rapid deterioration in the vision of the patient and improved after administration of steroids.
Introduction
Pituitary macroadenoma is a relatively common tumour of the central nervous system (CNS) accounting for almost 15% of all primary brain tumors and almost 25% of benign primary brain tumors. [1] The clinical presentation of these tumors vary depending on the functional status of the tumors, features of hypopituitarism if the pituitary gland is involved or compressed by the tumor and myriad of visual field defects/visual acuity disturbances depending on the size of the tumor or degree of involvement of the visual apparatus. [2] Almost exclusively, the anterior visual pathway is involved by pituitary tumors due to varying degrees of mass effect or compression of the anterior visual pathway. [2] Edema of the optic tract due to pituitary macroadenoma is a very rare finding on magnetic resonance imaging (MRI) compared to craniopharyngiomas. We describe a case of pituitary macroadenoma which was associated with bilateral optic tract edema as demonstrated on MRI.
Case Report
A 74-year-old female known case of Type II diabetes mellitus, primary hypertension and deep venous thrombosis (DVT) of the left leg on tablet warfarin, was admitted to our hospital for the evaluation of upper gastrointestinal bleed. The patient had no complaints of any visual problems before this admission and had complaints of mild global headache on and off for the past 4-5 months. There was no history of sudden worsening of her headache associated with visual deterioration in the past. After 5 days of admission to the hospital, the patient complaints of rapidly worsening eyesight which was not associated with any change in the character of her headache.
Clinical and neurological evaluation revealed visual acuity of perception of hand movement in the left eye at 3 feet distance and only perception of light in the right eye. Pupils were bilaterally 04 mm and reacting to light. Rest of the systemic and neurological examination was unremarkable. Perimetry for visual field defects could not performed due to the poor visual acuity of the patient. The visual evoked potential was not recordable. Endocrinological evaluation did not reveal any hormonal disturbances. In view of the rapid deterioration of the vision and MRI findings of bilateral optic tract edema, injection dexamethasone 4 mg IV QID was started for the patient and the patient was planned for trans nasal transsphenoidal excision of the tumor. Since the patient had deranged international normalized ratio (2.10), she could not be taken up for surgery immediately which carried a high risk of bleeding in the intra-and post-operative period. After 3 days of administration of injection dexamethasone, the patient had improvement in her vision. The patient was not willing for any surgical intervention because of her age, comorbidities, and significant risk of bleeding in her case because of the medications for DVT. She has been kept on follow-up for visual complaints.
Discussion
Pituitary tumors are relatively common tumors of CNS, and there incidence reported in literature is 15% of all primary brain tumors. [3] One of the modes of presentation of these tumors is a combination of various types of visual defects as characterized in the detailed ophthalmologic evaluation. These visual deficits are produced by pituitary macroadenomas by causing various degrees of compression on the anterior visual apparatus mainly the optic chiasma. The visual loss also occurs due to long-standing compression on the optic nerve leading to its atrophy which is indirectly demonstrated on fundus examination by optic disc pallor. MRI of the visual apparatus in pituitary macroadenoma reveals various degrees of compression and splaying of the optic chiasma over the tumour which is the cause of visual deficits in these patients.
However, vary rarely do we have findings in the posterior optic apparatus on imaging in patients with pituitary adenomas. Optic tract edema as visualized on MRI is more commonly associated with craniopharyngioma rather than pituitary macroadenoma. In the study published by Nagahata et al. [4] optic tract edema was detected in five of the eight patients with craniopharyngioma, whereas none of the patients with pituitary macroadenoma (n = 15) or tuberculum sellae meningiomas (n = 06) revealed optic tract edema on MRI. More recently Hirunpat et al. [3] in their article found optic tract edema in 7 of 11 patients with craniopharyngiomas whereas no optic tract edema was seen 28 pituitary macroadenoma, 4 meningioma, and similar other rarer pathologies of sellar/suprasellar regions (hypothalamic hamartoma, germinoma, astrocytoma, and arachnoid cyst).
Optic tract edema in patients has been demonstrated on MRI the study by Saeki et al. [5] in which 4 out of 25 pituitary adenomas had these findings whereas 8 of 11 craniopharyngiomas had optic tract edema. However, there was no clinical correlation between optic tract edema and degree of visual abnormalities detected in this study.
Our patient did not have any visual complaints to start with but developed visual complaints in a short period without any features of apoplexy. MRI showed bilateral optic tract edema which could be the cause of her rapid deterioration of vision. Improvement noticed in her vision after administration of steroids further substantiates our theory.
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